These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

310 related items for PubMed ID: 16411207

  • 1. Weighing the risks of G-CSF administration, leukopheresis, and standard marrow harvest: ethical and safety considerations for normal pediatric hematopoietic cell donors.
    Pulsipher MA, Nagler A, Iannone R, Nelson RM.
    Pediatr Blood Cancer; 2006 Apr; 46(4):422-33. PubMed ID: 16411207
    [Abstract] [Full Text] [Related]

  • 2. [Collection of hematopoietic progenitor cells from healthy donors].
    Bojanić I, Cepulić BG, Mazić S.
    Acta Med Croatica; 2009 Jun; 63(3):237-44. PubMed ID: 19827352
    [Abstract] [Full Text] [Related]

  • 3. Blood stem cell procurement: donor safety issues.
    Anderlini P, Przepiorka D, Körbling M, Champlin R.
    Bone Marrow Transplant; 1998 Jun; 21 Suppl 3():S35-9. PubMed ID: 9712491
    [Abstract] [Full Text] [Related]

  • 4. Follow-up of healthy donors receiving granulocyte colony-stimulating factor for peripheral blood progenitor cell mobilization and collection. Results of the Spanish Donor Registry.
    de la Rubia J, de Arriba F, Arbona C, Pascual MJ, Zamora C, Insunza A, Martínez D, Paniagua C, Díaz MA, Sanz MA.
    Haematologica; 2008 May; 93(5):735-40. PubMed ID: 18387976
    [Abstract] [Full Text] [Related]

  • 5. Acute lung Injury in a healthy donor during mobilization of peripheral blood stem cells using granulocyte-colony stimulating factor alone.
    Arimura K, Inoue H, Kukita T, Matsushita K, Akimot M, Kawamata N, Yamaguchi A, Kawada H, Ozak A, Arima N, Te C.
    Haematologica; 2005 Mar; 90(3):ECR10. PubMed ID: 15753051
    [Abstract] [Full Text] [Related]

  • 6. Granulocyte-colony stimulating factor administration to healthy individuals and persons with chronic neutropenia or cancer: an overview of safety considerations from the Research on Adverse Drug Events and Reports project.
    Tigue CC, McKoy JM, Evens AM, Trifilio SM, Tallman MS, Bennett CL.
    Bone Marrow Transplant; 2007 Aug; 40(3):185-92. PubMed ID: 17563736
    [Abstract] [Full Text] [Related]

  • 7. Donation of stem cells from blood or bone marrow: results of a randomised study of safety and complaints.
    Heldal D, Brinch L, Tjønnfjord G, Solheim BG, Egeland T, Gadeholt G, Albrechtsen D, Aamodt G, Evensen SA.
    Bone Marrow Transplant; 2002 Mar; 29(6):479-86. PubMed ID: 11960266
    [Abstract] [Full Text] [Related]

  • 8. Three to six year follow-up of normal donors who received recombinant human granulocyte colony-stimulating factor.
    Cavallaro AM, Lilleby K, Majolino I, Storb R, Appelbaum FR, Rowley SD, Bensinger WI.
    Bone Marrow Transplant; 2000 Jan; 25(1):85-9. PubMed ID: 10654020
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Healthy sibling donation of G-CSF primed stem cells: a call for research.
    Pentz RD.
    Pediatr Blood Cancer; 2006 Apr; 46(4):407-8. PubMed ID: 16395683
    [No Abstract] [Full Text] [Related]

  • 11. Safety and efficacy of allogeneic PBSC collection in normal pediatric donors: the pediatric blood and marrow transplant consortium experience (PBMTC) 1996-2003.
    Pulsipher MA, Levine JE, Hayashi RJ, Chan KW, Anderson P, Duerst R, Osunkwo I, Fisher V, Horn B, Grupp SA.
    Bone Marrow Transplant; 2005 Feb; 35(4):361-7. PubMed ID: 15608659
    [Abstract] [Full Text] [Related]

  • 12. [Collection of peripheral hematopoietic stem cells for transplantation from volunteer donors--siblings of the patients].
    Mayer J, Korístek Z, Krahulová M, Pospísil Z, Doubek M, Klabusay M, Brychtová Y, Hoffová V, Cernanská J, Krejcí M, Vorlícek J.
    Vnitr Lek; 2001 Sep; 47 Suppl 1():15-28. PubMed ID: 11693058
    [Abstract] [Full Text] [Related]

  • 13. The use of cytokine-stimulated healthy donors in allogeneic stem cell transplantation.
    Cesaro S, Marson P, Gazzola MV, De Silvestro G, Destro R, Pillon M, Calore E, Messina C, Zanesco L.
    Haematologica; 2002 Aug; 87(8 Suppl):35-41. PubMed ID: 12412388
    [Abstract] [Full Text] [Related]

  • 14. Unusual adverse events following peripheral blood stem cell (PBSC) mobilisation using granulocyte colony stimulating factor (G-CSF) in healthy donors.
    Hilbe W, Nussbaumer W, Bonatti H, Thaler J, Niederwieser D, Nachbaur D.
    Bone Marrow Transplant; 2000 Oct; 26(7):811-3. PubMed ID: 11042668
    [Abstract] [Full Text] [Related]

  • 15. Allogeneic stem cell transplantation with peripheral blood stem cells mobilized by pegylated G-CSF.
    Hill GR, Morris ES, Fuery M, Hutchins C, Butler J, Grigg A, Roberts A, Bradstock K, Szer J, Kennedy G, Morton J, Durrant S.
    Biol Blood Marrow Transplant; 2006 Jun; 12(6):603-7. PubMed ID: 16737933
    [Abstract] [Full Text] [Related]

  • 16. Long-term bone marrow culture data are the most powerful predictor of peripheral blood progenitor cell mobilization in healthy donors.
    López-Holgado N, Pata C, Villarón E, Sánchez-Guijo F, Alberca M, Martín A, Corral M, Sánchez-Abarca I, Pérez-Simón JA, San Miguel JF, del Cañizo MC.
    Haematologica; 2005 Mar; 90(3):353-9. PubMed ID: 15749668
    [Abstract] [Full Text] [Related]

  • 17. Use of G-CSF in matched sibling donor pediatric allogeneic transplantation: a consensus statement from the Children's Oncology Group (COG) Transplant Discipline Committee and Pediatric Blood and Marrow Transplant Consortium (PBMTC) Executive Committee.
    Grupp SA, Frangoul H, Wall D, Pulsipher MA, Levine JE, Schultz KR.
    Pediatr Blood Cancer; 2006 Apr; 46(4):414-21. PubMed ID: 16463346
    [Abstract] [Full Text] [Related]

  • 18. Peripheral blood stem cell mobilization with granulocyte colony-stimulating factor and a harvesting procedure in pediatric donors.
    Kawano Y, Takaue Y, Watanabe T, Watanabe A, Iwai A, Kuroda Y.
    Bone Marrow Transplant; 1998 Jun; 21 Suppl 3():S32-4. PubMed ID: 9712490
    [Abstract] [Full Text] [Related]

  • 19. Short- and long-term haematological surveillance of healthy donors of allogeneic peripheral haematopoietic progenitors mobilized with G-CSF: a single institution prospective study.
    Tassi C, Tazzari PL, Bonifazi F, Giudice V, Nannetti A, Ricci F, Rizzi S, Bandini G, Conte R.
    Bone Marrow Transplant; 2005 Aug; 36(4):289-94. PubMed ID: 15968277
    [Abstract] [Full Text] [Related]

  • 20. Short and long-term safety of lenograstim administration in healthy peripheral haematopoietic progenitor cell donors: a single centre experience.
    Martino M, Console G, Dattola A, Callea I, Messina G, Moscato T, Massara E, Irrera G, Fedele R, Gervasi A, Bresolin G, Iacopino P.
    Bone Marrow Transplant; 2009 Aug; 44(3):163-8. PubMed ID: 19182833
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.